Status:
COMPLETED
Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome
Lead Sponsor:
Ipsen
Conditions:
Myofascial Pain Syndromes
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of th...
Eligibility Criteria
Inclusion
- Moderate-severe pain in upper back
- Myofascial pain syndrome for more than 6 months
- Active trigger points in upper back
Exclusion
- Fibromyalgia and other non-myofascial pain conditions of upper back
- Duration of myofascial pain syndrome no longer than 24 months
- Steroid injections during previous 3 months
- Anaesthetic injection at trigger points during previous 1 month
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 18 2006
Estimated Enrollment :
381 Patients enrolled
Trial Details
Trial ID
NCT00134810
Start Date
March 1 2005
End Date
May 18 2006
Last Update
November 22 2019
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Pain Treatment Centre, Anesthesiology & Resuscitation, St Ann Teaching Hospital
Brno, Czechia, 656 91
2
Dept Neurology, Teaching Hospital Olomouc
Olomouc, Czechia, 775 20
3
Institute of Rheumatology
Prague, Czechia, 12850
4
Neurology Clinic, Klinikum der Ruhr-Universitat Bochum
Bochum, Germany, 44789